{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for "ORPHAN DRUG" in comments (approximate match)
Status:
Investigational
Source:
INN:apazunersen [INN]
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
INN:cavrotolimod [INN]
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
NCT03842969: Phase 3 Interventional Completed Huntington Disease
(2019)
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
NCT04153149: Phase 3 Interventional Active, not recruiting Transthyretin Amyloidosis (ATTR) With Cardiomyopathy
(2019)
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Class:
NUCLEIC ACID
Status:
Investigational
Source:
NCT01593072: Phase 1 Interventional Withdrawn Ebola Hemorrhagic Fever
(2012)
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
NCT02226965: Phase 2 Interventional Completed Lymphoma, Diffuse Large B-Cell
(2014)
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
NCT02658175: Phase 3 Interventional Completed Familial Chylomicronemia Syndrome
(2015)
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
NCT02974322: Phase 3 Interventional Withdrawn Crohn Disease
(2017)
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
NCT01493960: Phase 3 Interventional Completed Colitis, Ulcerative
(2011)
Source URL:
Class:
NUCLEIC ACID